DEFITELIO is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Jazz Pharmaceuticals, Inc.. The primary component is Defibrotide Sodium.
Product ID | 68727-800_0173efe0-e4e2-41f6-b044-81f707120906 |
NDC | 68727-800 |
Product Type | Human Prescription Drug |
Proprietary Name | DEFITELIO |
Generic Name | Defibrotide Sodium |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2016-03-30 |
Marketing Category | NDA / NDA |
Application Number | NDA208114 |
Labeler Name | Jazz Pharmaceuticals, Inc. |
Substance Name | DEFIBROTIDE SODIUM |
Active Ingredient Strength | 80 mg/mL |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2016-03-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA208114 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2016-03-30 |
Marketing Category | NDA |
Application Number | NDA208114 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2016-03-30 |
Ingredient | Strength |
---|---|
DEFIBROTIDE SODIUM | 80 mg/mL |
SPL SET ID: | 2c3db989-d7ad-41ed-9ebf-698dcf6c24ec |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
DEFITELIO 87638258 5652544 Live/Registered |
Gentium S.r.l. 2017-10-09 |
DEFITELIO 87034509 5487126 Live/Registered |
Gentium S.r.l. 2016-05-12 |
DEFITELIO 79099301 4162914 Live/Registered |
Gentium S.r.l. 2011-05-16 |